advertisement

---

Crabb DP 9

Showing records 1 to 9 | Display all abstracts from Crabb DP

60159 Latanoprost for open-angle glaucoma (UKGTS): a randomised, multicentre, placebo-controlled trial
Garway-Heath DF
Lancet 2015; 385: 1295-1304

---

60172 Areas of the visual field important during reading in patients with glaucoma
Burton R
Japanese Journal of Ophthalmology 2015; 59: 94-102

---

60193 Disease severity in newly diagnosed glaucoma patients with visual field loss: trends from more than a decade of data
Boodhna T
Ophthalmic and Physiological Optics 2015; 35: 225-230

---

60159 Latanoprost for open-angle glaucoma (UKGTS): a randomised, multicentre, placebo-controlled trial
Crabb DP
Lancet 2015; 385: 1295-1304

---

60172 Areas of the visual field important during reading in patients with glaucoma
Saunders LJ
Japanese Journal of Ophthalmology 2015; 59: 94-102

---

60193 Disease severity in newly diagnosed glaucoma patients with visual field loss: trends from more than a decade of data
Crabb DP
Ophthalmic and Physiological Optics 2015; 35: 225-230

---

60159 Latanoprost for open-angle glaucoma (UKGTS): a randomised, multicentre, placebo-controlled trial
Bunce C
Lancet 2015; 385: 1295-1304

---

60172 Areas of the visual field important during reading in patients with glaucoma
Crabb DP
Japanese Journal of Ophthalmology 2015; 59: 94-102

---

60159 Latanoprost for open-angle glaucoma (UKGTS): a randomised, multicentre, placebo-controlled trial
Lascaratos G; Amalfitano F; Anand N; Azuara-Blanco A; Bourne RR; Broadway DC; Cunliffe IA; Diamond JP; Fraser SG; Ho TA; Martin KR; McNaught AI; Negi A; Patel K; Russell RA; Shah A; Spry PG; Suzuki K; White ET; Wormald
Lancet 2015; 385: 1295-1304

---